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The first aim of this study was to quantify cell density in cervical intervertebral discs 
(IVDs) and endplates of varying age and degeneration grade. The second aim was 
to analyze glycosaminoglycan (GAG) content in cervical IVDs and their endplates.
Sixty cervical IVDs were excised from 30 human cadavers, not later than 24 hours 
post-mortem. Each sample underwent sectioning. Half of each sample underwent 
GAG content analysis using the dimethylmethylene blue binding assay. The other 
half underwent histological processing, histological degeneration grading, and cell 
density assessment using the Abercrombie method.
The nucleus pulposus (NP) (4218 ±417 cells/mm3) had significantly higher cell den-
sity than the anterior annulus fibrosus (AF) (3283 ±438 cells/mm3; p < 0.0001), and 
similar cell density (4464 ±551 cells/mm3; p = 0.36) to the posterior AF. Cell densi-
ty was similar throughout the different regions of the endplate. The NP (619 ±178 
µg/mg dry weight) had a significantly higher GAG content than both the anterior 
(428 ±199 µg/mg dry weight; p < 0.0001) and posterior AF (524 ±218 µg/mg  
dry weight; p < 0.0001).
In conclusion, this study introduces detailed 3D maps of cervical IVD and end-
plate cell density and GAG content. Furthermore, it shows that cervical IVDs and 
their endplates only slightly differ, in terms of cell density and GAG content, from 
lumbar IVDs.
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bral disc.
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Introduction
The intervertebral discs (IVD) are cylindrical, fi-
brocartilaginous structures responsible for articula-
tion between vertebral bodies. They allow for flexion, 
extension, and rotation of the otherwise rigid anteri-
or portion of the vertebral column [1]. Macroscopi-
cally the IVD can be divided into an outer annulus 
fibrosus (AF) which surrounds a centrally located 
nucleus pulposus (NP). This “two-compartment” 
structure allows the IVD to successfully function as 
a load-bearing unit [2]. The IVD is bordered, from 
the cranial and caudal sides, by the endplates, which 
possess an osseous as well as a hyaline cartilage com-
ponent [3]. One of their main roles is to prevent the 
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highly hydrated NP from bulging into the adjacent 
vertebrae.
With ageing the IVD undergoes changes, in terms 
of its extracellular matrix composition, as well as cell 
density and character [4, 5, 6]. From early childhood, 
the blood supply to the IVD and the endplates de-
creases [7], together with cell density [8], leading 
to an increased incidence of structural defects. Since 
IVD cells are responsible for matrix formation and 
maintenance, their proper quantity, quality, and dis-
tribution in the regional compartments of the IVD 
may be crucial in preventing degeneration. However, 
changes in cell density with ageing thus far have only 
been shown in lumbar IVDs [8, 9]. Recent years have 
brought about new treatment modalities for disc de-
generative disease (DDD) – these include autolo-
gous or allogeneic cell transplantation [8, 10, 11], 
mesenchymal stem cell transfer [12], and genetical-
ly modified cell transformation. However, for these 
treatments to be effective one would have to know 
the cell density baseline values which can be expected 
when treating individuals of a certain age and level of 
IVD degeneration. The current literature lacks infor-
mation on cell density age- and degeneration-related 
changes in human cervical IVDs and endplates. As 
a result the number of cells implanted into IVDs, in 
various animal experiments, varies significantly [10, 
11, 12]. This emphasizes the need to establish cell 
density values in regard to patient age and IVD de-
generation. Such knowledge would allow future cell-
based therapies to deliver adequate numbers of cells 
with each treatment.
The correct spatial distribution of proteoglycans 
(with glycosaminoglycan chains – GAG) in the IVD 
is crucial for the discs’ physiological swelling behav-
iors, streaming potential, and compressive properties 
[13]. During IVD degeneration, proteolytic frag-
mentation of large and small proteoglycans may in-
duce or inhibit essential inflammatory response path-
ways, altering the ability of the extracellular matrix 
to maintain its structural integrity [14, 15]. Loss of 
proteoglycans in the NP is a clear sign of early IVD 
degeneration [16]. Thus far, several studies have in-
vestigated the distribution of sulfated GAGs in lum-
bar IVDs, in the sagittal [17] as well as coronal and 
axial [18] directions. However, no such study has 
been performed in cervical IVDs. As IVD degener-
ation is driven partially by aging [15], it is not easy 
to differentiate changes that are a consequence of ag-
ing itself from those that develop because of tissue 
degeneration and the accompanying repair process. 
Additional research is needed to determine how age 
and degeneration influence IVD and endplate extra-
cellular matrix composition.
The first aim of this study was to quantify cell 
density in cervical IVDs and endplates of varying age 
and degeneration grade to produce cell density maps, 
which would provide a knowledge base for future 
cell-based therapies for cervical DDD. As IVD cells 
are directly responsible for proteoglycan production, 
the second aim of the study was to analyze GAG con-
tent in cervical IVDs and their endplates. This part of 
the study aimed at providing additional insight into 
IVD and endplate physiology and pathology, and 
was meant to supply data for future computer mod-
eling of IVD behavior.
Material and methods
Material acquisition
Sixty cervical IVDs were excised from 30 human 
cadavers (at the Department of Forensic Medicine, 
Jagiellonian University Medical College), using the 
anterior approach, not later than 24 hours post-mor-
tem [19]. The material was excised in one block 
comprising vertebral bodies, IVDs, endplates and 
blood vessels supplying these structure, wrapped in 
saline-soaked gauze, vacuum-sealed to prevent dehy-
dration, and kept at 4°C for transport, until further 
processing. Excision started at the level of the lower 
half of the C4 vertebra and ended at the level of the 
upper half of the C6 (Fig. 1). 
The study inclusion criterion was the ability to 
excise a section of the anterior spinal column (from 
the lower half of the C4 vertebra to the upper half of 
the C6), with the anterior and posterior longitudinal 
ligaments and blood vessels supplying the vertebrae. 
Study exclusion criteria were: (1) injury to the cervi-
cal spine, preventing excision of the required section; 
(2) previous cervical spine surgery; (3) receiving che-
motherapy in the last 12 months; (4) previous radia-
tion therapy to the perispinal region; (5) long-stand-
ing paralysis (6 or more months); (6) ankylosing 
spondylitis.
Material processing
On the same day each sample was unpacked from 
the vacuum-sealed container. Intervertebral discs 
were isolated by removing extraneous soft tissue and 
adjacent vertebrae using a scalpel/microscalpel under 
an operating microscope (OPMI Pico, Zeiss). Special 
attention was paid not to remove the cartilaginous 
endplates (both cranial and caudal), and leave them 
intact with the IVDs. To assure this a thin layer of 
subchondral bone was left attached to the IVD.
Each IVD was then dissected, using a custom 
made 3 mm × 3 mm die-cutter, in order to obtain 
an array of square samples spanning the sagittal di-
rection from anterior to posterior (4-7 sections, de-
pending on IVD size) and also spanning the coronal 
direction from left lateral to central to right lateral 
locations (5-8 sections) [18]. Additionally, IVD sec-
tions from 5 different regions (anterior, posterior, 
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lateral, and nucleus pulposus) were further divided 
– first into 2 sections (sagittal plane). Then, one of 
the two sections was further divided into 5 sections 
to evaluate the distribution of GAG content in the 
axial direction. Material acquisition and processing 
are depicted in Fig. 1.
Macroscopic degeneration grading and tissue 
processing
During die-cutting, each IVD was sectioned at 
the midsagittal plane, which allowed for macroscopic 
IVD degeneration scoring according to Thompson’s 
5-grade classification [20]. Grade 1 corresponds to 
a healthy IVD, while grade 5 represents the most se-
verely degenerated IVD. Each specimen was assessed 
by two of the authors, and the grade was averaged. 
Next, the samples chosen for further histological 
analysis (Fig. 1) were placed in a 10% solution of 
formaldehyde (pH 7.4) for a minimum of 14 days for 
fixing. The samples chosen for GAG content analysis 
were immediately processed (see below).
Macroscopic degeneration grading  
and histological processing
Microscopic IVD and endplate (both cranial and 
caudal) degeneration was assessed using the histolog-
ic degeneration score (HDS) [7]. In brief, the HDS 
semiquantitatively scores cellular organization (cell 
proliferation), cleft/tear formations, granular chang-
es, and mucoid degeneration in anterior/posterior 
annulus fibrosus (AF) and nucleus pulposus (NP) re-
gions. It produces a summary score separately for the 
AF/NP (0-22) and the endplate (0-18).
The NP/AF scores were grouped as follows [8]: 
group I: 0-2; group II: 3-7; group III: 8-12; group 
IV: 13-17; group V: 18-22 (tissue defects, scar). The 
EP scores were grouped as follows: group I: 0-2; 
group II: 3-5; group III: 6-9; group IV: 10-12; group 
V: 13-18 (tissue defects, scar, ossification). Group V 
did not encompass normal disc tissue and thus was 
not included in the calculation of cell density.
Tissue samples were acquired from the midsagittal 
and midcoronal planes of each of the IVD regions 
(Fig. 1). Fixed samples were decalcified, dehydrat-
ed, embedded in paraffin, sectioned midsagittally at 
4 µm, and stained with hematoxylin and eosin (HE), 
Masson-Goldner trichrome and alcian blue-PAS (De-
partment of Pathology, Jagiellonian University Med-
ical College). Each sample was assessed and scored, 
using light microscopy (Nikon Eclipse 80i), by two 
observers, and the final score per sample was aver-
aged [21].
Additional horizontal sections, of each sample, 
were prepared in the same manner with H&E stain-
ing to determine the calculated cell density using the 
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Fig. 1. Study material acquisition and processing 
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Abercrombie method [8, 22]. Each sample was pho-
tographed and analyzed using Java ImageJ (devel-
oped by Wayne Rasband) [23].
The degree of endplate calcification was analyzed 
as the percentage of calcified tissue (red on Mas-
son-Goldner trichrome staining) to the non-calcified 
part. The fact of endplate calcification was verified on 
corresponding HE stained samples. The percentage 
of calcification was averaged for all examined end-
plate regions.
Cell density analysis and cell nucleus correction 
factor
A morphometric analysis was performed to deter-
mine the cell number per analyzed region (Fig. 1) of 
IVD and EP, using sagittal slices. All measurements 
were performed using a light microscope (Nikon 
Eclipse 80i) with an ocular grid (10 × 10 fields). The 
number of cell nuclei was counted from the superi-
or to the inferior part of the section (magnification 
400×) [8]. Twenty consecutive grids in the anteri-
or-posterior dimension and a variable number of grids 
(depending on the thickness of the sample) in the su-
perior-inferior direction were analyzed. Different cell 
types were distinguished based on their morphology.
As the nuclei of IVD cells are usually larger than 
5 µm, they may appear in more than 1 section, which 
results in an overestimation of the total cell number. 
Abercrombie [22] developed a correction factor to 
determine cell density (T) including the number of 
nuclei (N) per area (N/mm2), the section thickness 
(S), and the diameter of the cell nucleus (D). Based on 
this method we included a correction factor of 240 to 
obtain the cell number per mm3. The number of cell 
nuclei was counted using ImageJ software.
Measuring GAG content
After dissection (Fig. 1) each sample was placed in 
pre-weighed vials, weighed, and lyophilized to obtain 
dry weights using a balance with ± 0.01 mg resolu-
tion (DV215CD, Ohaus).
Dry tissue was solubilized using proteinase K 
(0.5 mg/ml, Sigma Aldrich) and assayed for GAG 
content using the dimethylmethylene blue (DMMB) 
dye binding assay as previously described for disc tis-
sue [16]. The GAG content was calculated based on 
a standard curve using an aqueous solution of chon-
droitin sulfate sodium salt from shark cartilage (chon-
droitin 6-sulfate, Sigma Aldrich, cat. no. C4384). All 
GAG content measurements were performed in du-
plicate and expressed as µg/mg of dry tissue.
Statistical analysis
Statistical analysis was conducted using Statisti-
ca 10.0 (StatSoft). Elements of descriptive statistics 
were used (mean, standard deviation percentage dis-
tribution). Differences between groups were tested 
with the paired Student’s t test. To assess the correla-
tion between scores, Pearson’s correlation was used. 
Inter-rater reliability of the histologic assessment of 
cell density and the HDS was assessed using the in-
traclass correlation coefficient (ICC). Statistical sig-
nificance was set at p < 0.05.
Ethics
The research protocol was approved by the Jagiel-
lonian University Medical College Ethics Committee 
(registry number KBET/319/B/2012). The study was 
performed in accordance with the ethical standards 
laid down in the 1964 Declaration of Helsinki and 
its later amendments. The specimen excision method 
was chosen so as not to destabilize the cadaver’s spi-
nal column.
Results
The study group comprised 30 female and 30 
male IVDs. The mean age ± SD of the specimens 
was 51.4 ±19.5. The basic characteristics of the 
study group are presented in Table I.
Interobserver reliability
The interclass correlation coefficient for the as-
sessment of cell density from two randomly select-
ed midsagittal sections per Thompson degeneration 
grade with a total of 100 regions of interest (ROIs) 
displayed a very high reliability coefficient α of 0.92.
Cell density in the intervertebral disc
Cell density per chosen IVD region in relation to 
the HDS grade is presented in Table II. The average 
cell number differed significantly between the anteri-
or (3283 ±438 cells/mm3) and posterior (4464 ±551 
cells/mm3) AF (p < 0.0001). The NP (4218 ±417 
cells/mm3) had significantly higher cell density than 
the anterior AF (p < 0.0001) and similar cell density 
(p = 0.36) to the posterior AF. Comparison by side of 
AF showed no difference (p = 0.51) between the left 
(4875 ±378 cells/mm3) and right (4735 ±385 cells/
mm3) sides in terms of cell density.
The HDS negatively correlated with cell density 
in all of the IVD regions (r = –0.31-(–0.55); p < 
0.003). This correlation was strongest for the NP.
Age significantly negatively correlated with cell den- 
sity only in the anterior AF (r = –0.28; p = 0.009) 
and the NP (r = –0.37; p < 0.0001). Maps of aver-
age IVD cell density for typical 20-30, 40-50, 60-70, 
and 80-90 years old are shown in Fig. 2A.
There were no significant differences between sex-
es in terms of IVD cell density with the exception 
of the NP (males 3162 ±886 cells/mm3 vs. females 
5069 ±5269 cells/mm3; p < 0.001).
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Cell density in the endplate
Differences in cell density between the cranial and 
caudal endplates were not statistically significant 
(p > 0.05); thus the results were presented as an av-
erage value of cranial and caudal endplate cellularity.
Cell density per chosen endplate region in relation 
to the HDS grade is displayed in Table III. When com-
paring the average cell number between the endplate 
region underlying the anterior (18 624 ±1774 cells/
mm3) and posterior (18 829 ±1569 cells/mm3) AF 
no significant difference was noted (p = 0.89). The 
endplate region underlying the NP (19 744 ±1698 
cells/mm3) had similar cell density when compared 
to the anterior (p = 0.39) and posterior (p = 0.40) 
AF regions. Comparison by side of endplate region 
underlying the AF showed no difference (p = 0.93) 
between the left (18 463 ±1543 cells/mm3) and 
right (18 540 ±1622 cells/mm3) sides in terms of cell 
density.
The HDS significantly negatively correlated with 
cell density in all of the endplate regions (r = –0.72-
(–0.77); p < 0.0001). This correlation was strongest 
for the region underlying the posterior AF.
Age significantly negatively correlated with cell 
density in all of the endplate regions (r = –0.44-(–
0.53); p < 0.0001), and was strongest for the region 
underlying the anterior AF (r = –0.53; p < 0.0001). 
Maps of average endplate cell density for typical 20-
30, 40-50, 60-70, and 80-90 years old are shown in 
Fig. 2B.
Endplate calcification strongly negatively cor-
related with cell density in the endplate (r = –0.51- 
(–0.56); p < 0.0001).
There were no significant differences between sex-
es in terms of endplate cell density for all analyzed 
regions (p > 0.05).
Glycosaminoglycan content in the intervertebral 
disc
Glycosaminoglycan content per chosen IVD region 
in relation to the HDS grade is presented in Table IV. 
When comparing the average GAG content between 
the anterior (428 ±199 µg/mg dry weight) and pos-
Table I. Basic characteristics of the study group
parameter Female 
(n = 30)
male 
(n = 30)
tOtal 
(n = 60)
p-value1
Age (SD) 52.8
(19.8)
50.0
(19.4)
51.4
(19.5)
0.57
IVD degeneration
Thompson classification (SD)
2.6
(1.3)
3.2
(1.3)
2.9
(1.3)
0.08
IVD degeneration
HDS score (0-22) (SD)
12.0
(6.1)
14.3
(5.3)
13.1
(5.8)
0.13
Endplate degeneration
HDS score (0-18) (SD)
8.9
(5.3)
11.5
(4.8)
10.2
(5.2)
0.06
Endplate calcification [%] (SD) 28.4
(25.1)
44.1
(26.0)
36.2
(26.5)
0.02
IVD degeneration
Thompson classification vs. degree of endplate calcification [%] (SD)
Grade I 6.2
(2.6)
6.7
(0.6)
6.3
(2.1)
0.31
Grade II 13.2
(2.8)
17.7
(1.9)
14.8
(3.3)
< 0.0001
Grade III 29.6
(8.7)
37.1
(7.3)
34.4
(8.4)
0.0006
Grade IV 53.3
(6.9)
61.6
(4.8)
57.9
(7.0)
< 0.0001
Grade V 77.3
(8.5)
79.1
(2.8)
78.5
(5.2)
0.28
1 – for differences between females and males 
SD – standard deviation; IVD – intervertebral disc; HDS – histologic degeneration score
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terior (524 ±218 µg/mg dry weight) AF a signifi-
cant difference was noted (p < 0.001). The NP (619 
±178 µg/mg dry weight) had a significantly higher 
GAG content than both the anterior (p < 0.0001) 
and posterior AF (p < 0.0001). Comparison by side of 
AF showed no difference (p = 0.63) between the left 
(479 ±201 µg/mg dry weight) and right (470 ±192 
µg/mg dry weight) sides in terms of GAG content.
The HDS negatively correlated with GAG con-
tent in all of the IVD regions (r = –0.47-(–0.71); 
p < 0.0001). This correlation was strongest for the NP.
Age significantly negatively correlated with GAG 
content in all of the IVD regions (r = –0.60-(–0.90); 
p < 0.0001), and was strongest for the region of the 
NP. Maps of average IVD GAG content for typical 
20-30, 40-50, 60-70, and 80-90 years old are shown 
in Fig. 3A.
There were no significant differences between sex-
es in terms of GAG content in any of the IVD regions 
(p > 0.05).
Glycosaminoglycan content in the endplate
Differences in GAG content between the cranial 
and caudal endplates were not statistically significant 
(p > 0.05); thus the results were presented as an aver-
age value of cranial and caudal endplate GAG content.
Glycosaminoglycan content per chosen endplate 
region in relation to the HDS grade is presented in 
Table V. When comparing the average GAG content 
between the endplate region underlying the anteri-
or (169 ±52 µg/mg dry weight) and posterior (192 
±57 µg/mg dry weight) AF a significant difference 
was noted (p < 0.0001). The endplate region un-
derlying the NP (209 ±58 µg/mg dry weight) had 
significantly higher GAG content than the anterior 
(p < 0.0001) and posterior (p < 0.0001) AF regions. 
Comparison by side of endplate region underlying 
the AF showed no difference (p = 0.84) between the 
left (199 ±56 cells/mm3) and right (200 ±57 µg/mg 
dry weight) sides in terms of GAG content.
The HDS significantly negatively correlated with 
GAG content in all of the endplate regions (r = 
= –0.57-(–0.64); p < 0.0001). The correlation was 
strongest for the region underlying the NP.
Age significantly negatively correlated with GAG 
content in all of the endplate regions (r = –0.82- 
(–0.88); p < 0.0001), and was strongest for the re-
gions underlying the left and right AF. Maps of aver-
Table II. Cell density per intervertebral disc region in relation to the histologic grade of disc degeneration
ivd regiOn
[cell/mm3]
hds i hds ii hds iii hds iv
AOA 22124 (2333) 2412 (192) 1864 (211) 2586 (179)
AIA 22549 (2058) 2484 (188) 2225 (201) 2715 (124)
AONP 22182 (2035) 3790 (727) 4007 (914) 2624 (273)
NP 21462 (3577) 3521 (715) 4481 (564) 2599 (378)
PONP 24523 (962) 3850 (824) 3654 (1141) 2805 (326)
PIA 28662 (1061) 2891 (931) 2190 (338) 5139 (798)
POA 26623 (779) 2391 (595) 1908 (359) 4454 (669)
LLOA 19184 (906) 2821 (463) 2255 (303) 5273 (1063)
LLIA 20759 (401) 4914 (674) 4106 (473) 4930 (1576)
LONP 21124 (1894) 4364 (752) 3638 (827) 2761 (247)
RONP 21199 (2741) 3718 (887) 3667 (1160) 2598 (261)
RLIA 20663 (411) 4798 (647) 3744 (522) 4699 (1571)
RLOA 19868 (840) 3001 (668) 2163 (294) 5105 (1007)
Anterior AF 
(averaged)
22337 (1813) 2448 (188) 2045 (273) 2651 (165)
NP (averaged) 22098 (2238) 3849 (799) 3889 (978) 2677 (307)
Posterior AF 
(averaged)
27642 (1401) 2641 (801) 2049 (371) 4797 (805)
Values in brackets represent standard deviations.
HDS – histologic degeneration score; IVD – intervertebral disc; EP – endplate; AOA – anterior outer annulus; AIA – anterior inner annulus; PIA – posterior inner 
annulus; POA – posterior outer annulus; LLOA – left lateral outer annulus; LLIA – left lateral inner annulus; RLIA – right lateral inner annulus; RLOA – right 
lateral outer annulus; NP – nucleus pulposus; AONP – anterior outer nucleus pulposus; PONP – posterior outer nucleus pulposus; LONP – left outer nucleus pulposus; 
RONP – right outer nucleus pulposus; AF – annulus fibrosus.
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Please note the change in scale between different maps. Values are expressed as number of cells per mm3.
A1 – intervertebral disc (20-30 years old); B1 – endplate (20-30 years old); A2 – intervertebral disc (40-50 years old); B2 – endplate (40-50 years old);  
A3 – intervertebral disc (60-70 years old); B3 – endplate (60-70 years old); A4 – intervertebral disc (80-90 years old); B5 – endplate (80-90 years old). 
C – center; LI – left inner; LO – left outer; RI – right inner; RO – right outer; AO – anterior outer; AI – anterior inner; PI – posterior inner; PO – posterior outer.
Fig. 2. Three-dimensional maps of average intervertebral disc (A) and endplate (B) cell density shown for different age groups
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Table III. Cell density per endplate region in relation to the histologic grade of endplate degeneration
ep regiOn
[cell/mm3]
hds i hds ii hds iii hds iv
AOA 37252 (3408) 45174 (17896) 8925 (1438) 9538 (884)
AIA 35855 (4445) 40046 (9071) 8579 (1763) 9458 (1070)
AONP 36033 (3946) 50041 (13619) 8870 (1317) 13207 (2372)
NP 46639 (12563) 20779 (5995) 12135 (3084) 12703 (1839)
PONP 45596 (3108) 39961 (13779) 11821 (2003) 12551 (1712)
PIA 40745 (12186) 44512 (11810) 10842 (2365) 9541 (1035)
POA 35523 (12122) 27132 (5237) 12899 (2472) 9953 (959)
LLOA 35828 (8999) 40827 (11537) 10198 (2552) 9637 (1104)
LLIA 34843 (6904) 35117 (12003) 11681 (2235) 9506 (665)
LONP 47531 (6811) 45340 (11793) 12189 (3216) 13569 (2206)
RONP 46565 (7560) 41029 (8911) 12803 (3228) 12987 (2144)
RLIA 34805 (7937) 39635 (9556) 9928 (3145) 9992 (971)
RLOA 34617 (9562) 41427 (12338) 9474 (2657) 10009 (1096)
Anterior AF 
(averaged)
36554 (3806) 42610 (13888) 8752 (1589) 9498 (962)
NP (averaged) 44473 (8168) 39430 (14619) 11564 (2955) 13003 (2036)
Posterior AF 
(averaged)
38134 (11785) 35822 (12584) 11870 (2596) 9747 (1000)
Values in brackets represent standard deviations.
Table IV. Glycosaminoglycan content per intervertebral disc region in relation to the histologic grade of disc degenera-
tion 
ivd regiOn
[gag µ g/mg dry weight]
hds i hds ii hds iii hds iv hds v
AOA 471 (5.0) 385 (92) 393 (88) 268 (94) 181 (48)
AIA 805 (48) 690 (149) 662 (108) 526 (172) 364 (70)
AONP 864 (20) 802 (96) 744 (135) 598 (165) 467 (90)
NP 851 (28) 754 (129) 697 (122) 550 (141) 424 (84)
PONP 908 (12) 781 (88) 745 (121) 602 (158) 485 (90)
PIA 866 (5.0) 794 (79) 774 (98) 665 (147) 529 (95)
POA 609 (13) 481 (122) 447 (107) 316 (89) 236 (92)
LLOA 543 (98) 529 (78) 480 (113) 350 (104) 225 (97)
LLIA 898 (5.0) 730 (122) 716 (121) 517 (169) 368 (95)
LONP 879 (81) 767 (163) 742 (132) 548 (142) 435 (96)
RONP 882 (45) 776 (112) 726 (157) 555 (159) 418 (89)
RLIA 841 (35) 748 (114) 679 (123) 502 (152) 362 (90)
RLOA 587 (1.4) 477 (71) 484 (102) 359 (102) 219 (99)
Anterior AF (averaged) 638 (195) 537 (198) 528 (168) 397 (190) 273 (110)
NP (averaged) 877 (39) 776 (116) 731 (132) 570 (152) 446 (91)
Posterior AF (averaged) 737 (148) 637 (189) 611 (195) 491 (214) 383 (175)
Values in brackets represent standard deviations.
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Please note the change in scale between different maps. Values are expressed as µg of GAG per mg of dry tissue weight.
A1 – intervertebral disc (20-30 years old); B1 – endplate (20-30 years old); A2 – intervertebral disc (40-50 years old); B2 – endplate (40-50 years old);  
A3 – intervertebral disc (60-70 years old); B3 – endplate (60-70 years old); A4 – intervertebral disc (80-90 years old); B5 – endplate (80-90 years old). 
C – center; LI – left inner; LO – left outer; RI – right inner; RO – right outer; AO – anterior outer; AI – anterior inner; PI – posterior inner; PO – posterior outer.
Fig. 3. Three-dimensional maps of average glycosaminoglycan content in the intervertebral disc (A) and endplate (B) shown for 
different age groups 
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Table V. Glycosaminoglycan content per endplate region in relation to histologic grade of disc degeneration 
ep regiOn
[gag µ g/mg dry weight]
hds i hds ii hds iii hds iv hds v
AOA 178 (37) 182 (16) 168 (31) 153 (25) 123 (25)
AIA 225 (50) 247 (31) 213 (54) 192 (52) 139 (41)
AONP 242 (31) 260 (29) 241 (46) 222 (43) 151 (44)
NP 252 (36) 254 (23) 240 (50) 224 (36) 158 (47)
PONP 245 (23) 258 (29) 236 (45) 223 (39) 157 (50)
PIA 220 (62) 244 (36) 221 (44) 191 (45) 137 (38)
POA 252 (42) 251 (37) 210 (56) 204 (46) 156 (38)
LLOA 238 (39) 251 (34) 214 (46) 195 (46) 148 (35)
LLIA 246 (51) 266 (28) 227 (50) 206 (52) 162 (43)
LONP 231 (53) 261 (31) 231 (57) 198 (55) 155 (42)
RONP 237 (52) 263 (33) 224 (53) 201 (51) 153 (37)
RLIA 250 (42) 271 (26) 227 (49) 210 (49) 155 (40)
RLOA 232 (48) 242 (27) 218 (55) 195 (49) 153 (39)
Anterior AF (averaged) 202 (48) 215 (41) 190 (49) 172 (44) 131 (35)
NP (averaged) 242 (38) 259 (27) 234 (49) 214 (46) 155 (44)
Posterior AF (averaged) 236 (53) 247 (36) 215 (50) 198 (45) 147 (39)
Values in brackets represent standard deviations.
age endplate GAG content for typical 20-30, 40-50, 
60-70, and 80-90 years old are shown in Fig. 3B.
Endplate calcification strongly negatively cor-
related with cell density of the endplate (r = –0.58- 
(–0.68); p < 0.0001).
There were no significant differences between sex-
es in terms of endplate GAG content for all analyzed 
regions (p > 0.05).
Figure 4 shows IVD GAG content variation in the 
axial direction in regard to HDS grade.
Cell density and glycosaminoglycan content 
correlations in the intervertebral disc and the 
endplates
Weak correlations existed between IVD cell density 
and cell density in corresponding EP regions (r = 0.25-
0.33; p < 0.01). This was not true only for the NP 
(p > 0.05).
Cell density in the IVD weakly correlated with 
IVD GAG content (r = 0.30-0.37; p > 0.03) only 
in the NP regions. In the endplate no correlations 
were found between cell density and GAG content 
in the region underlying the NP. However, moder-
ate correlations between GAG content and cell den-
sity were found in endplate regions underlying the 
right and left sides of the inner AF (r = 0.39-0.48; 
p < 0.01), and in the regions underlying the anterior 
(r = 0.37; p < 0.02) and posterior outer AF (r = 0.39; 
p < 0.01).
Discussion
This study aimed at establishing cell density val-
ues as well as providing data on GAG content across 
different regions of the cervical IVD and its end-
plates. Recent years have seen a multitude of studies 
focusing on the analysis of changes in the extracel-
lular matrix of the IVD during ageing [4, 5, 7, 13, 
14, 15, 16, 17, 18]. However, despite tremendous 
research efforts, we still lack knowledge regarding 
cell density and GAG content throughout the IVD. 
To the authors’ best knowledge this is the first study 
to analyze cell density and GAG content in cervical 
IVDs and their endplates.
For our study we decided to use the well-validated 
Abercrombie method [22] of cell counting. Based on 
the previous experience of Liebscher et al. [8] using 
the Abercrombie method, we determined the “true” 
cell density in a three-dimensional space using 2-di-
mensional histological sections. As IVD cells have 
nuclei larger than 4 µm (section thickness), the em-
ployed method prevented us from missing any nuclei 
during counting.
Cell density in the intervertebral disc  
and the endplates
Overall, taking into account the IVD, cell density 
was highest in the NP and gradually decreased out-
wards, with the anterior AF having significantly low-
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Please note the change in scale between different graphs.
IVD – intervertebral disc; GAG – glycosaminoglycan; HDS – histological degeneration score; AF – annulus fibrosus; NP – nucleus pulposus.
Fig. 4. Intervertebral disc glycosaminoglycan content variation in the axial direction in regard to histological degenera-
tion score grade 
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er cell density than the posterior AF. The differences 
in the anterior-posterior cell density might originate 
from the fact that nutrient supply to the posterior 
part of the IVD is generally thought to be better 
[24]. Nerlich et al. [25] also found that posterior ves-
sels can be located deeper in the posterior AF in ju-
venile discs. In consequence, there is a small chance 
that some of these vessels persist, at least for a certain 
period of time, into adulthood, though generally this 
is considered unlikely [25]. There is still no agree-
ment as to whether cell density decreases outwards 
from the NP [9] or remains constant throughout 
the IVD [8], as different studies present conflicting 
results. As this is the first study to analyze cervical 
IVDs, we support the theory that cell density is not 
homogeneous throughout the whole IVD. No signif-
icant side-related variations in cell density were not-
ed. However, this might be explained by the fact that 
the IVD receives nutrients not only through the end-
plate but also from segmental artery branches that 
run along the vertebral bodies and allow nutrients to 
diffuse to the IVD from its sides [26].
With progressing degeneration, cell density in the 
IVD decreased. Age did not have a strong effect on 
cell density, which remained more or less constant 
with progressing age of the patients, with the ex-
ception of the NP and the anterior AF, where cell 
density decreased with ageing. This finding is in line 
with previous studies [8] which found that the most 
significant decrease of IVD cell density takes place 
between the 3rd and 16th year of life. This period wit-
nesses dramatic changes occurring in the IVD, with 
the volume of the IVD increasing with a simultaneous 
decrease in blood supply (due to vascular regression) 
[25]. This results in a reduced diffusion rate [27] and 
therefore lower oxygen and glucose concentrations 
in the NP region, leading to a harsher cell environ-
ment [28]. This “vicious cycle” is further potentiat-
ed by endplate calcification, which impedes nutrient 
diffusion even more [21]. The above facts, together 
with age, which seemingly does not correlate with 
a decrease in cell density, might lead us to conclude 
that degenerative changes cause impairment of cell 
function rather than their death. This finding is in 
line with previously reported results [8, 16, 29]. It 
further elucidates the fact that even though in HDS 
grade IV IVDs a rise in cell density can be seen, these 
new cells remain “inactive” and do not produce extra-
cellular matrix elements; thus they cannot contribute 
to IVD regeneration. Though the overall cell density 
does not significantly decrease with age, Fig. 2 shows 
that with age the spatial distribution of cells changes. 
Progressive loss of cells in the anterior and middle 
part (and not in the outer parts) of the IVD can be 
seen, further supporting the theory that nutrition 
is the key factor in preventing age- and degenera-
tion-related IVD changes (as with endplate calcifi-
cation the outer regions of the IVD tend to receive 
more nutrients).
Cranial and caudal endplates exhibited similar cell 
density and GAG content, as was also found by Ro-
driguez et al. [30]. The endplate presented similar 
cell density throughout all of its structure, in some 
cases “matching” IVD regions of low cell density 
with endplate areas of high cell density (e.g. Fig. 
2.A1 and B1). As could be expected, increasing end-
plate calcification leads to a decrease in the number 
of cells. However, contrary to what we found in the 
IVD, in the endplate age significantly negatively cor-
related with endplate cell density. This finding might 
either stem from simple endplate calcification (which 
markedly progressed with age [31]) and physical de-
struction of cells or suggest that IVD cells are more 
resistant in nature, due to the “harsher” environment 
[28] that is present in the IVD when compared with 
the endplate.
Glycosaminoglycans in the intervertebral discs 
and the endplates
Proteoglycan molecules within the endplate ma-
trix are necessary for the control of solute transport 
and maintenance of water content throughout the 
IVD. Depletion of proteoglycans from the endplate 
cartilage is associated with loss of proteoglycans from 
the NP [32]. The further consequence is that proteo-
glycan loss would ultimately lead to degeneration of 
the IVD [33].
Similarly to other studies [18] we found that the 
highest concentration of GAGs can be found in the 
region of the NP. Overall GAG content, in both the 
IVD and the endplates, followed cell density values. 
GAG production is considered a measure of IVD/
endplate cell activity [30]. Interestingly, sagittal and 
coronal variations in IVD GAG content were rather 
high when compared to previous studies [18]. How-
ever, this was only true for the IVD, while the end-
plate, regardless of donor age or IVD/endplate de-
generation, had similar GAG content throughout all 
of its regions (Fig. 3B1-4). Axial variations in IVD 
GAG content were small and resembled those from 
lumbar IVDs [18].
Age and HDS score significantly negatively cor-
related with GAG content in both the IVD and the 
endplate. It is well recognized that GAG content de-
creases with degeneration [34]. Additionally, Rodri-
guez et al. [30] found that endplate porosity increases 
with age, while GAG content, as in our study, de-
creases. Collectively, the presented findings support 
the theory that endplate porosity increases with age, 
and that this may be an adaptive response to a reduc-
tion of nuclear swelling pressure. It is worth addition-
ally underlining the fact that GAG content decreases 
with ageing, as this decrease might be suggestive of 
an age-related generalized decrease in cellular bio-
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chemical activity [15]. While it is hard to general-
ize the significance of this decrease, it is suggestive 
of a decreasing cellular response and extra-cellular 
matrix production that may have a significant role 
in how tissue injury is managed as a consequence of 
ageing.
Gender did not have an influence either on cell 
density or GAG content in both the IVD and the 
endplates. This finding is in line with previous studies 
[8, 30].
The strong points of this study include a large 
study group (one of the largest to date), a detailed 
histological analysis combined with a significant 
number of examined IVD and endplate regions in 
axial, coronal, and sagittal directions. To the authors’ 
best knowledge this is the first study to assess cell 
density and GAG content in cervical IVDs and their 
endplates. However, this study has also one draw-
back. The youngest specimen in our study came from 
a 19-year-old person. This prevented us from analyz-
ing how cell density and GAG content change during 
the years (3-16) when the IVD and the endplates un-
dergo the greatest changes.
Conclusions
To conclude, this study introduces several detailed 
3D maps of cervical IVD and cervical endplate cell 
density and GAG content. The most important 
prerequisite for successful IVD cell injection in cell-
based tissue engineering approaches is a clear under-
standing of the actual cell numbers in normal and 
degenerated IVDs. Knowledge from this study may 
partially bridge the gap on IVD cell numbers in nor-
mal and degenerated discs.
Furthermore, the results from this study show that 
cervical IVDs and their endplates only slightly differ, 
in terms of cell density and GAG content, from their 
lumbar counterparts.
Additionally, this study provides new informa-
tion characterizing GAG content distributions in the 
three primary directions in the IVD. This informa-
tion may be helpful for future computer modeling of 
human IVD tissue. The presented data also reveal an 
overall age-related trend towards decreased IVD cel-
lular metabolic activity as manifested by decreasing 
concentrations of GAGs.
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